市場調査レポート

商品コード

感染症の世界市場 2025～2029年

Global Infectious Disease Market 2025-2029

出版日: 2025年02月22日
発行: TechNavio
ページ情報: 英文 223 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 358,650円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 573,840円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.46円

全表示
概要
目次

概要

サンプル依頼リストに入れる

感染症市場は2024-2029年に1,608億米ドル、予測期間中のCAGRは14.7%で成長すると予測されます。

当レポートでは、感染症市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、感染症の有病率の増加、感染症に対する意識の高まり、強力な医薬品パイプラインによって牽引されています。

市場範囲
基準年	2025
終了年	2029
予測期間	2025-2029
成長モメンタム	加速
前年比2025年	12.5%
CAGR	14.7%
増分額	1,608億米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間の感染症市場の成長を促進する主な要因の一つとして、新薬の開発を挙げています。また、合併・買収の増加や新しいパターンの感染症の出現は、市場の大きな需要につながります。

地域別セグメンテーション
地域別比較
北米：市場規模と予測 2024-2029
欧州：市場規模と予測 2024-2029
アジア：市場規模と予測 2024-2029
世界のその他の地域：市場規模と予測 2024-2029
米国：市場規模と予測 2024-2029
カナダ：市場規模と予測 2024-2029
英国：市場規模と予測 2024-2029
中国：市場規模と予測 2024-2029
ドイツ：市場規模と予測 2024-2029
日本：市場規模と予測 2024-2029
フランス：市場規模と予測 2024-2029
イタリア：市場規模と予測 2024-2029
インド：市場規模と予測 2024-2029
オランダ：市場規模と予測 2024-2029
市場機会：地域情勢別

第13章促進要因・課題・機会・抑制要因

市場促進要因
市場の課題
促進要因と課題の影響
市場の機会・抑制要因

第14章競合情勢

概要
競合情勢
混乱の状況
業界のリスク

第15章競合分析

企業プロファイル
企業の市場ポジショニング
Pfizer Inc.
Gilead Sciences, Inc.
GlaxoSmithKline plc（GSK）
Merck & Co., Inc.
Johnson & Johnson
AbbVie Inc.
Sanofi S.A.
AstraZeneca plc
BioNTech SE
Novartis International AG
Hoffmann-La Roche AG
Bristol-Myers Squibb Company
Eli Lilly and Company
Takeda Pharmaceutical Co. Ltd
Boehringer Ingelheim GmbH
Mylan N.V.
CSL Limited
Amgen Inc.
Bayer AG
Moderna, Inc.

第16章付録

Product Code: IRTNTR71174

The infectious disease market is forecasted to grow by USD 160.8 billion during 2024-2029, accelerating at a CAGR of 14.7% during the forecast period. The report on the infectious disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of infectious diseases, growing awareness of infectious diseases, and strong drug pipeline.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	12.5%
CAGR	14.7%
Incremental Value	$160.8 bn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's infectious disease market is segmented as below:

By Product

Drugs
Vaccines

By End-user

Hospital
Multispecialty clinic
Others

By Type

Bacterial infections
Viral infections
Fungal infections
Parasitic infections

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the development of novel drugs as one of the prime reasons driving the infectious disease market growth during the next few years. Also, increasing mergers and acquisitions and emergence of new patterns of infectious diseases will lead to sizable demand in the market.

The report on the infectious disease market covers the following areas:

Infectious Disease Market sizing
Infectious Disease Market forecast
Infectious Disease Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading infectious disease market vendors that include Abbott Laboratories, Becton Dickinson and Co., Bio RAD Laboratories Inc., BioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., Perkin Elmer Inc., QIAGEN N.V., QuidelOrtho Corp., Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech PLC. Also, the infectious disease market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Infectious Disease Market 2019 - 2023
- Historic Market Size - Data Table on Global Infectious Disease Market 2019 - 2023 ($ billion)
5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ billion)
5.3 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
5.4 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ billion)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

6.1 Impact of AI on the global infectious disease market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
8.3 Drugs - Market size and forecast 2024-2029
- Chart on Drugs - Market size and forecast 2024-2029 ($ billion)
- Data Table on Drugs - Market size and forecast 2024-2029 ($ billion)
- Chart on Drugs - Year-over-year growth 2024-2029 (%)
- Data Table on Drugs - Year-over-year growth 2024-2029 (%)
8.4 Vaccines - Market size and forecast 2024-2029
- Chart on Vaccines - Market size and forecast 2024-2029 ($ billion)
- Data Table on Vaccines - Market size and forecast 2024-2029 ($ billion)
- Chart on Vaccines - Year-over-year growth 2024-2029 (%)
- Data Table on Vaccines - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Product
- Market opportunity by Product ($ billion)
- Data Table on Market opportunity by Product ($ billion)

9 Market Segmentation by End-user

9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
9.3 Hospital - Market size and forecast 2024-2029
- Chart on Hospital - Market size and forecast 2024-2029 ($ billion)
- Data Table on Hospital - Market size and forecast 2024-2029 ($ billion)
- Chart on Hospital - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital - Year-over-year growth 2024-2029 (%)
9.4 Multispecialty clinic - Market size and forecast 2024-2029
- Chart on Multispecialty clinic - Market size and forecast 2024-2029 ($ billion)
- Data Table on Multispecialty clinic - Market size and forecast 2024-2029 ($ billion)
- Chart on Multispecialty clinic - Year-over-year growth 2024-2029 (%)
- Data Table on Multispecialty clinic - Year-over-year growth 2024-2029 (%)
9.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by End-user
- Market opportunity by End-user ($ billion)
- Data Table on Market opportunity by End-user ($ billion)

10 Market Segmentation by Type

10.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
10.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
10.3 Bacterial infections - Market size and forecast 2024-2029
- Chart on Bacterial infections - Market size and forecast 2024-2029 ($ billion)
- Data Table on Bacterial infections - Market size and forecast 2024-2029 ($ billion)
- Chart on Bacterial infections - Year-over-year growth 2024-2029 (%)
- Data Table on Bacterial infections - Year-over-year growth 2024-2029 (%)
10.4 Viral infections - Market size and forecast 2024-2029
- Chart on Viral infections - Market size and forecast 2024-2029 ($ billion)
- Data Table on Viral infections - Market size and forecast 2024-2029 ($ billion)
- Chart on Viral infections - Year-over-year growth 2024-2029 (%)
- Data Table on Viral infections - Year-over-year growth 2024-2029 (%)
10.5 Fungal infections - Market size and forecast 2024-2029
- Chart on Fungal infections - Market size and forecast 2024-2029 ($ billion)
- Data Table on Fungal infections - Market size and forecast 2024-2029 ($ billion)
- Chart on Fungal infections - Year-over-year growth 2024-2029 (%)
- Data Table on Fungal infections - Year-over-year growth 2024-2029 (%)
10.6 Parasitic infections - Market size and forecast 2024-2029
- Chart on Parasitic infections - Market size and forecast 2024-2029 ($ billion)
- Data Table on Parasitic infections - Market size and forecast 2024-2029 ($ billion)
- Chart on Parasitic infections - Year-over-year growth 2024-2029 (%)
- Data Table on Parasitic infections - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Type
- Market opportunity by Type ($ billion)
- Data Table on Market opportunity by Type ($ billion)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.10 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.11 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.12 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 The Netherlands - Market size and forecast 2024-2029
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Market positioning of companies
- Matrix on companies position and classification
15.3 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key offerings
15.4 Gilead Sciences, Inc.
- Gilead Sciences, Inc. - Overview
- Gilead Sciences, Inc. - Product / Service
- Gilead Sciences, Inc. - Key offerings
15.5 GlaxoSmithKline plc (GSK)
- GlaxoSmithKline plc (GSK) - Overview
- GlaxoSmithKline plc (GSK) - Product / Service
- GlaxoSmithKline plc (GSK) - Key offerings
15.6 Merck & Co., Inc.
- Merck & Co., Inc. - Overview
- Merck & Co., Inc. - Product / Service
- Merck & Co., Inc. - Key offerings
15.7 Johnson & Johnson
- Johnson & Johnson - Overview
- Johnson & Johnson - Product / Service
- Johnson & Johnson - Key offerings
15.8 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key offerings
15.9 Sanofi S.A.
- Sanofi S.A. - Overview
- Sanofi S.A. - Product / Service
- Sanofi S.A. - Key offerings
15.10 AstraZeneca plc
- AstraZeneca plc - Overview
- AstraZeneca plc - Product / Service
- AstraZeneca plc - Key offerings
15.11 BioNTech SE
- BioNTech SE - Overview
- BioNTech SE - Product / Service
- BioNTech SE - Key offerings
15.12 Novartis International AG
- Novartis International AG - Overview
- Novartis International AG - Product / Service
- Novartis International AG - Key offerings
15.13 Hoffmann-La Roche AG
- Hoffmann-La Roche AG - Overview
- Hoffmann-La Roche AG - Product / Service
- Hoffmann-La Roche AG - Key offerings
15.14 Bristol-Myers Squibb Company
- Bristol-Myers Squibb Company - Overview
- Bristol-Myers Squibb Company - Product / Service
- Bristol-Myers Squibb Company - Key offerings
15.15 Eli Lilly and Company
- Eli Lilly and Company - Overview
- Eli Lilly and Company - Product / Service
- Eli Lilly and Company - Key offerings
15.16 Takeda Pharmaceutical Co. Ltd
- Takeda Pharmaceutical Co. Ltd - Overview
- Takeda Pharmaceutical Co. Ltd - Product / Service
- Takeda Pharmaceutical Co. Ltd - Key offerings
15.17 Boehringer Ingelheim GmbH
- Boehringer Ingelheim GmbH - Overview
- Boehringer Ingelheim GmbH - Product / Service
- Boehringer Ingelheim GmbH - Key offerings
15.18 Mylan N.V.
- Mylan N.V. - Overview
- Mylan N.V. - Product / Service
- Mylan N.V. - Key offerings
15.19 CSL Limited
- CSL Limited - Overview
- CSL Limited - Product / Service
- CSL Limited - Key offerings
15.20 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key offerings
15.21 Bayer AG
- Bayer AG - Overview
- Bayer AG - Product / Service
- Bayer AG - Key offerings
15.22 Moderna, Inc.
- Moderna, Inc. - Overview
- Moderna, Inc. - Product / Service
- Moderna, Inc. - Key offerings

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

感染症の世界市場 2025～2029年

Global Infectious Disease Market 2025-2029

目次

第1章エグゼクティブサマリー

第2章 Technavio別分析

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：製品別

第9章市場セグメンテーション：エンドユーザー別

第10章市場セグメンテーション：タイプ別

第11章顧客情勢

第12章地域別情勢

第13章促進要因・課題・機会・抑制要因

第14章競合情勢

第15章競合分析

第16章付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Product

9 Market Segmentation by End-user

10 Market Segmentation by Type

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

感染症の世界市場 2025～2029年

Global Infectious Disease Market 2025-2029

目次

第1章 エグゼクティブサマリー

第2章 Technavio別分析

第3章 市場情勢

第4章 市場規模

第5章 市場規模実績

第6章 定性分析

第7章 ファイブフォース分析

第8章 市場セグメンテーション：製品別

第9章 市場セグメンテーション：エンドユーザー別

第10章 市場セグメンテーション：タイプ別

第11章 顧客情勢

第12章 地域別情勢

第13章 促進要因・課題・機会・抑制要因

第14章 競合情勢

第15章 競合分析

第16章 付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Product

9 Market Segmentation by End-user

10 Market Segmentation by Type

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

第1章エグゼクティブサマリー

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：製品別

第9章市場セグメンテーション：エンドユーザー別

第10章市場セグメンテーション：タイプ別

第11章顧客情勢

第12章地域別情勢

第13章促進要因・課題・機会・抑制要因

第14章競合情勢

第15章競合分析

第16章付録